Related references
Note: Only part of the references are listed.Low concentrations of serum n-3 polyunsaturated fatty acids in non-alcoholic fatty liver disease patients with liver injury
Tomonori Kishino et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2011)
Patatin-Like Phospholipase Domain-Containing 3 I148M Polymorphism, Steatosis, and Liver Damage in Chronic Hepatitis C
Luca Valenti et al.
HEPATOLOGY (2011)
PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence
Edmondo Falleti et al.
LIVER INTERNATIONAL (2011)
Human Fatty Liver Disease: Old Questions and New Insights
Jonathan C. Cohen et al.
SCIENCE (2011)
Increased hepatic fat in overweight Hispanic youth influenced by interaction between genetic variation in PNPLA3 and high dietary carbohydrate and sugar consumption
Jaime N. Davis et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2010)
Association of the rs738409 polymorphism in PNPLA3 with liver damage and the development of nonalcoholic fatty liver disease
Kikuko Hotta et al.
BMC MEDICAL GENETICS (2010)
Association of Diabetes Duration and Diabetes Treatment With the Risk of Hepatocellular Carcinoma
Manal M. Hassan et al.
CANCER (2010)
Unravelling the pathogenesis of fatty liver disease: patatin-like phospholipase domain-containing 3 protein
Stefano Romeo et al.
CURRENT OPINION IN LIPIDOLOGY (2010)
Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma: A Weighty Connection
Brad Q. Starley et al.
HEPATOLOGY (2010)
The Association of Genetic Variability in Patatin-Like Phospholipase Domain-Containing Protein 3 (PNPLA3) with Histological Severity of Nonalcoholic Fatty Liver Disease
Yaron Rotman et al.
HEPATOLOGY (2010)
Homozygosity for the Patatin-Like Phospholipase-3/Adiponutrin I148M Polymorphism Influences Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
Luca Valenti et al.
HEPATOLOGY (2010)
A Sequence Variation (I148M) in PNPLA3 Associated with Nonalcoholic Fatty Liver Disease Disrupts Triglyceride Hydrolysis
Shaoqing He et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Epidemiology and Natural History of Non-Alcoholic Steatohepatitis
Curtis K. Argo et al.
CLINICS IN LIVER DISEASE (2009)
A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans
A. Kotronen et al.
DIABETOLOGIA (2009)
Association Between Hypothyroidism and Hepatocellular Carcinoma: A Case-Control Study in the United States
Manal M. Hassan et al.
HEPATOLOGY (2009)
Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005
Sean F. Altekruse et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The association of family history of liver cancer with hepatocellular carcinoma: A case-control study in the United States
Manal M. Hassan et al.
JOURNAL OF HEPATOLOGY (2009)
A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity
Silvia Sookoian et al.
JOURNAL OF LIPID RESEARCH (2009)
Population-Based Genome-wide Association Studies Reveal Six Loci Influencing Plasma Levels of Liver Enzymes
Xin Yuan et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2008)
Effect of different types of smoking and synergism with Hepatitis C virus on risk of hepatocellular carcinoma in American men and women: Case-control study
Manal M. Hassan et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Stefano Romeo et al.
NATURE GENETICS (2008)
Cross-talk between peroxisome proliferator-activated receptor δ and cytosolic phospholipase A2α/cyclooxygenase-2/prostaglandin E2 signaling pathways in human hepatocellular carcinoma cells
Lihong Xu et al.
CANCER RESEARCH (2006)
Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation
JK Reddy et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2006)
Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: A population-based study
HB El-Serag et al.
JOURNAL OF HEPATOLOGY (2006)
Mechanisms of disease: pathway-selective insulin resistance and microvascular complications of diabetes
PH Groop et al.
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2005)
Insulin resistance: A metabolic pathway to chronic liver disease
E Bugianesi et al.
HEPATOLOGY (2005)
Expression, regulation, and triglyceride hydrolase activity of Adiponutrin family members
AC Lake et al.
JOURNAL OF LIPID RESEARCH (2005)
Thalidomide in the treatment of patients with hepatocellular carcinoma - A phase II trial
YZ Patt et al.
CANCER (2005)
Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma
YZ Patt et al.
CANCER (2004)
Narrative review: Hepatobiliary disease in type 2 diabetes mellitus
KG Tolman et al.
ANNALS OF INTERNAL MEDICINE (2004)
Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity
JD Browning et al.
HEPATOLOGY (2004)
Molecular mediators of hepatic steatosis and liver injury
JD Browning et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Phase II trial of systemic continuous fluorouracil and subcutaneous recombinant interferon Alfa-2b for treatment of hepatocellular carcinoma
YZ Patt et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Risk factors for hepatocellular carcinoma: Synergism of alcohol with viral hepatitis and diabetes mellitus
MM Hassan et al.
HEPATOLOGY (2002)
Share Paper
